With more than 23,000 confirmed cases and almost 1,500 deaths from COVID-19, Medtech services in Ireland are gearing up to try ease the pressure on acute services. Now, Dublin-based Medtech provider S3 Connected Health has partnered with senior respiratory consultants across Ireland to develop a new clinical support tool to combat COVID-19.
ACORRD – which stands for the Assessment of COVID-19 Risk of Respiratory Deterioration – is the result of round-the-clock efforts by clinicians and Dublin-based digital health solutions provider S3 Connected Health; supported by The Royal College of Surgeons in Ireland (RCSI) and The Royal College of Physicians in Ireland (RCPI), reports S3 Connected Health.
Following receipt of a derogation from the HPRA and the Department of Health, ACORRD reached doctors at Beaumont Hospital, which has the largest cohort of COVID-19 patients in Ireland, in a record 10 days. Three more major hospitals are currently using ACCORD with over 100 clinicians piloting the use of the solution on over 1,000 patients.
“Ireland’s hospitals are working tirelessly and doing a stellar job at looking after coronavirus patients, said Professor Richard Costello, senior respiratory consultant, Beaumont Hospital and lead clinician on the ACORRD project. “However, with the number of cases rapidly increasing, we urgently needed to find a solution that enabled our hospital teams to cope with this crisis by optimizing and scaling acute respiratory care delivery for all affected patients. And with additional clinical staff being pulled in from other departments to boost our respiratory care teams, we also needed something to provide clinicians less experienced in this area with the critical knowledge and decision support to care for patients.”
ACORRD enables clinicians to quickly and appropriately triage COVID-19 patients using the web-based application on their smartphone – defines a novel measure of patient status called the COVID Critical Care Index (CCCI), and helps determine the best course of treatment based on:
- The mode of oxygen delivery
- Key patient vitals, including respiratory rate and oxygen saturation levels
CCCI assessments are repeated on an ongoing basis, enabling ACORRD to visualize trends, track disease progression, assist in the early identification of patient deterioration, and provide timely advice to the care team on the appropriate clinical considerations.
“The adoption we’ve seen from clinicians has been very encouraging; non-respiratory clinicians, in particular, are finding it a very valuable resource. We are also starting to see some interesting clinical data from ACORRD, which is helping us better understand the trajectory of the disease and help plan for future requirements; to have the insight into the progression of this uncharted disease is invaluable,” Costello said.